We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Oncology Update.
- Authors
Smart, Michael
- Abstract
The article offers information on several new treatments, clinical trials, and oncology care. It says that Crizotinib (Xalkori®) was already approved by the U.S. Food and Drug Administration (FDA) for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC). Furthermore, brentuximab vedotin (Adcetris™) was approved by FDA as a cure to Hodgkin lymphoma after autologous hematopoietic progenitor stem cell transplantation (AHPSCT).
- Subjects
THERAPEUTIC use of monoclonal antibodies; PROTEIN kinases; ACETAMINOPHEN; LUNG cancer; LYMPHOMAS; MELANOMA; WORLD Wide Web; INFORMATION resources; CHRONIC myeloid leukemia; THERAPEUTICS
- Publication
Oncology Nursing Forum, 2011, Vol 38, Issue 6, p739
- ISSN
0190-535X
- Publication type
Article
- DOI
10.1188/11.ONF.739-740